Longitudinal associations between Vitamin D metabolites and Sarcopenia in older Australian men: The concord health and aging in men project

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 73, Issue 1, 2018, Pages 131-138

  Hirani, Vasant ^a   Cumming, Robert G ^a,b   Naganathan, Vasi ^a   Blyth, Fiona ^a   Couteur, David G Le ^a   Hsu, Benjumin ^a   Handelsman, David J ^a   Waite, Louise M ^a   Seibel, Markus J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Calcitriol; Older men; Population study; Sarcopenia; Vitamin D

Indexed keywords

1,25-DIHYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; PARATHYROID HORMONE; VITAMIN D;

AGED; AGING; ANALOGS AND DERIVATIVES; AUSTRALIA; BLOOD; BODY MASS; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DIETARY SUPPLEMENT; FOLLOW UP; HUMAN; INCIDENCE; MALE; MOTOR ACTIVITY; MULTICENTER STUDY; MUSCLE STRENGTH; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; RADIOIMMUNOASSAY; RETROSPECTIVE STUDY; SARCOPENIA; SKELETAL MUSCLE; TIME FACTOR;

AGED; AGING; AUSTRALIA; BIOMARKERS; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MOTOR ACTIVITY; MUSCLE STRENGTH; MUSCLE, SKELETAL; PARATHYROID HORMONE; PROGNOSIS; RADIOIMMUNOASSAY; RETROSPECTIVE STUDIES; SARCOPENIA; TIME FACTORS; VITAMIN D;

EID: 85030766825     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glx086     Document Type: Article

References (41)

1. Fielding RA, Vellas B, Evans WJ, et al.Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12:249-256. doi:10.1016/j.jamda.2011.01.003.
2. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing. 2010;39:412-423. doi:10.1093/ageing/afq034
3. Sayer AA, Robinson SM, Patel HP, Shavlakadze T, Cooper C, Grounds MD. New horizons in the pathogenesis, diagnosis and management of sarcopenia. Age Ageing. 2013;42:145-150. doi:10.1093/ageing/afs191.
4. Mithal A, Wahl DA, Bonjour JP, et al. IOF Committee of Scientific Advisors (CSA) Nutrition Working Group Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int. 2009; 20: 1807-1820. doi:10.1007/s00198-009-0954-6.
5. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of vitamin D: A meta-Analysis of randomised controlled trials. BMJ. 2009; 339:b3692. doi:10.1136/bmj.b3692
6. Annweiler C, Schott AM, Berrut G, Fantino B, Beauchet O. Vitamin D-related changes in physical performance: A systematic review. J Nutr Health Aging. 2009;13:893-898.
7. Park S, Ham JO, Lee BK. A positive association of vitamin D deficiency and sarcopenia in 50 year old women, but not men. Clin Nutr. 2014;33:900-905. doi:10.1016/j.clnu.2013.09.016
8. Marantes I, Achenbach SJ, Atkinson EJ, Khosla S, Melton LJ 3rd, Amin S. Is vitamin D a determinant of muscle mass and strength? J Bone Miner Res. 2011;26:2860-2871. doi:10.1002/jbmr.510
9. Scott D, Blizzard L, Fell J, Ding C, Winzenberg T, Jones G. A prospective study of the associations between 25-hydroxy-vitamin D, sarcopenia progression and physical activity in older adults. Clin Endocrinol (Oxf). 2010;73:581-587. doi:10.1111/j.1365-2265.2010.03858.x
10. Visser M, Deeg DJ, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): The Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab. 2003;88:5766-5772. doi:10.1210/jc.2003-030604
11. Rosen CJ, Adams JS, Bikle DD, et al. The nonskeletal effects of vitamin D: An Endocrine Society scientific statement. Endocr Rev. 2012;33:456-492. doi:10.1210/er.2012-1000.
12. Windelinckx A, De Mars G, Beunen G, et al. Polymorphisms in the vitamin D receptor gene are associated with muscle strength in men and women. Osteoporos Int. 2007;18:1235-1242. doi:10.1007/s00198-007-0374-4.
13. Cumming RG, Handelsman D, Seibel MJ, et al. Cohort profile: The Concord Health and Ageing in Men Project (CHAMP). Int J Epidemiol. 2009;38:374-378. doi:10.1093/ije/dyn071
14. Heymsfield SB, Smith R, Aulet M, et al. Appendicular skeletal muscle mass: measurement by dual-photon absorptiometry. Am J Clin Nutr. 1990;52:214-218.
15. Cawthon PM, Peters KW, Shardell MD, et al. Cutpoints for low appendicular lean mass that identify older adults with clinically significant weakness. J Gerontol A Biol Sci Med Sci. 2014;69:567-575. doi:10.1093/gerona/glu023
16. Alley DE, Shardell MD, Peters KW, et al. Grip strength cutpoints for the identification of clinically relevant weakness. J Gerontol A Biol Sci Med Sci. 2014;69:559-566. doi:10.1093/gerona/glu011
17. Cawthon PM, Peters KW, Shardell MD, et al. Cutpoints for low appendicular lean mass that identify older adults with clinically significant weakness. J Gerontol A Biol Sci Med Sci. 2014;69:567-575. doi:10.1093/gerona/glu023
18. Hirani V, Naganathan V, Cumming RG, et al. Associations between frailty and serum 25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D concentrations in older Australian men: The Concord Health and Ageing in Men Project. J Gerontol A Biol Sci Med Sci. 2013;68:1112-1121. doi:10.1093/gerona/glt059
19. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-612. doi:10.7326/0003-4819-150-9-200905050-00006
20. Washburn RA, Smith KW, Jette AM, Janney CA. The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol. 1993;46:153-162.
21. Shiekh J, Yesavage J. Geriatric Depression Scale: recent findings and development of a short version. In: Brink T, eds. Clinical Gerontology: A Guide to Assessment and Intervention. New York: Howarth Press; 1986.
22. Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
23. Jorm AF. A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation. Psychol Med. 1994;24:145-153.
24. Katz S, Downs TD, Cash HR, Grotz RC. Progress in development of the index of ADL. Gerontologist. 1970;10:20-30.
25. Ziegler A, Kastner C, Blettner M. Generalized estimating equations: An annotate bibliography. Biom J. 1998;40:115-139. doi:10.1002/(SICI)1521-4036(199806)40:23.0.CO;2-6.
26. Agresti A. Categorical Data Analysis. 2. New York: Wiley; 2002.
27. National Kidney Foundation. Kidney disease outcomes quality initiative clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. National Kidney Foundation; 2002. http://www. kidney.org/professionals/KDOQI/guidelines.cfm.
28. Abboud M, Puglisi DA, Davies BN, et al. Evidence for a specific uptake and retention mechanism for 25-hydroxyvitamin D (25OHD) in skeletal muscle cells. Endocrinology. 2013;154:3022-3030. doi:10.1210/en.2012-2245.
29. Halfon M, Phan O, Teta D. Vitamin D: A review on its effects on muscle strength, the risk of fall, and frailty. Biomed Res Int. 2015;2015:953241. doi:10.1155/2015/953241
30. Zamboni M, Zoico E, Tosoni P, et al. Relation between vitamin D, physical performance, and disability in elderly persons. J Gerontol A Biol Sci Med Sci. 2002;57:M7-11.
31. Iannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci. 2002;57:M772-M777.
32. Houston DK, Cesari M, Ferrucci L, et al. Association between vitamin D status and physical performance: The InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2007;62:440-446. doi:10.1093/gerona/57.12:M772
33. Srikuea R, Zhang X, Park-Sarge OK, Esser KA. VDR and CYP27B1 are expressed in C2C12 cells and regenerating skeletal muscle: potential role in suppression of myoblast proliferation. Am J Physiol Cell Physiol. 2012;303:C396-C405. doi:10.1152/ajpcell.00014.2012.
34. Olsson K, Saini A, Str-berg A, et al. Evidence for Vitamin D receptor expression and direct effects of 1α, 25(OH)2D3 in human skeletal muscle precursor cells. Endocrinology. 2016;157:98-111. doi:10.1210/en.2015-1685
35. Dawson-Hughes B. Serum 25-hydroxyvitamin D and muscle atrophy in the elderly. Proc Nutr Soc. 2012;71:46-49. doi:10.1017/S0029665111003260
36. Boland R, de Boland AR, Marinissen MJ, Santillan G, Vazquez G, Zanello S. Avian muscle cells as targets for the secosteroid hormone 1, 25-dihydroxy-vitamin D3. Mol Cell Endocrinol. 1995;114:1-8.
37. Slovik DM, Adams JS, Neer RM, Holick MF, Potts JT Jr. Deficient production of 1, 25-dihydroxyvitamin D in elderly osteoporotic patients. N Engl J Med. 1981;305:372-374. doi:10.1056/NEJM198108133050704
38. Bischoff HA, Borchers M, Gudat F, et al. In situ detection of 1, 25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem J. 2001;33:19-24.
39. Stockton KA, Mengersen K, Paratz JD, Kandiah D, Bennell KL. Effect of vitamin D supplementation on muscle strength: A systematic review and meta-Analysis. Osteoporos Int. 2011;22:859-871. doi:10.1007/s00198-010-1407-y
40. Holden CA, McLachlan RI, Pitts M, et al. Men in Australia Telephone Survey (MATeS): A national survey of the reproductive health and concerns of middle-Aged and older Australian men. Lancet. 2005;366:218-224. doi:10.1016/S0140-6736(05)66911-5
41. Stevens LA, Schmid CH, Greene T, et al. Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis. 2010;56:486-495. doi:10.1053/j.ajkd.2010.03.026